Exonate receives Wellcome Trust funding

Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD)   Early stage biotechnology company targeting ophthalmology and other areas of unmet medical need Cambridge, UK. Monday 6th February 2017 –...